
Sale companies partner on bisphosphonate issue
The yearling sale season in North America began in July as the Thoroughbred racing industry continued to grapple with long-standing horse welfare and safety issues pushed into the national forefront by the equine fatalities at Santa Anita. Among the issues in the discussion is the use of bisphosphonates in young horses headed for the sales ring.








